WO2005072050A9 - Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer - Google Patents

Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer Download PDF

Info

Publication number: WO2005072050A9
Authority: WO; WIPO (PCT)
Prior art keywords: assays; diagnosis; methods; amino acid; acid sequences
Prior art date: 2004-01-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

PCT/IB2005/000433

Other languages

French (fr)

Other versions

WO2005072050A2 (en

Inventor

Amir Toporik

Dvir Dahary

Rotem Sorek

Sarah Pollock

Zurit Levine

Pinchas Akiva

Alexander Diber

Amit Novik

Osnat Sella-Tavor

Michal Ayalon-Soffer

Shira Walach

Shirley Sameah-Greenwald

Ronen Shemesh

Naomi Keren

Maxim Shklar

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Compugen USA Inc

Original Assignee

Compugen USA Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-01-27

Filing date

2005-01-27

Publication date

2010-01-14

2005-01-27 Application filed by Compugen USA Inc filed Critical Compugen USA Inc

2005-01-27 Priority to JP2006550364A priority Critical patent/JP2007520217A/en

2005-01-27 Priority to EP05718182A priority patent/EP1732943A4/en

2005-01-27 Priority to CA002554440A priority patent/CA2554440A1/en

2005-01-27 Priority to AU2005207882A priority patent/AU2005207882A1/en

2005-01-27 Priority claimed from US11/043,842 external-priority patent/US20060183131A1/en

2005-08-11 Publication of WO2005072050A2 publication Critical patent/WO2005072050A2/en

2006-07-27 Anticipated expiration legal-status Critical

2010-01-14 Publication of WO2005072050A9 publication Critical patent/WO2005072050A9/en

Status Ceased legal-status Critical Current

Classifications

- G01N33/57515—
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Biophysics (AREA)
Pathology (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Peptides Or Proteins (AREA)

PCT/IB2005/000433 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer Ceased WO2005072050A2 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
JP2006550364A JP2007520217A (en)	2004-01-27	2005-01-27	Novel nucleotide and amino acid sequences, and assays and methods of use for breast cancer diagnosis using the same
EP05718182A EP1732943A4 (en)	2004-01-27	2005-01-27	NOVEL NUCELOTIDE AND AMINO ACID SEQUENCES, AND THEIR ASSAY AND METHODS FOR THE DIAGNOSIS OF BREAST CANCER
CA002554440A CA2554440A1 (en)	2004-01-27	2005-01-27	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
AU2005207882A AU2005207882A1 (en)	2004-01-27	2005-01-27	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Applications Claiming Priority (51)

Application Number	Priority Date	Filing Date	Title
USNONE		2001-08-31
US53912904P	2004-01-27	2004-01-27
US53912804P	2004-01-27	2004-01-27
US60/539,129		2004-01-27
US60/539,128		2004-01-27
US62091604P	2004-10-22	2004-10-22
US62087404P	2004-10-22	2004-10-22
US62085304P	2004-10-22	2004-10-22
US62091804P	2004-10-22	2004-10-22
US62092404P	2004-10-22	2004-10-22
US62091704P	2004-10-22	2004-10-22
US62065604P	2004-10-22	2004-10-22
US62097404P	2004-10-22	2004-10-22
US62100404P	2004-10-22	2004-10-22
US62097504P	2004-10-22	2004-10-22
US60/620,924		2004-10-22
US60/620,656		2004-10-22
US60/620,975		2004-10-22
US60/620,974		2004-10-22
US60/620,918		2004-10-22
US60/620,853		2004-10-22
US60/621,004		2004-10-22
US60/620,917		2004-10-22
US60/620,916		2004-10-22
US60/620,874		2004-10-22
US62113104P	2004-10-25	2004-10-25
US60/621,131		2004-10-25
US62811204P	2004-11-17	2004-11-17
US62811104P	2004-11-17	2004-11-17
US62816704P	2004-11-17	2004-11-17
US62825104P	2004-11-17	2004-11-17
US62012304P	2004-11-17	2004-11-17
US62817804P	2004-11-17	2004-11-17
US62814504P	2004-11-17	2004-11-17
US62823104P	2004-11-17	2004-11-17
US62813404P	2004-11-17	2004-11-17
US62815604P	2004-11-17	2004-11-17
US62810104P	2004-11-17	2004-11-17
US60/628,178		2004-11-17
US60/628,111		2004-11-17
US60/620,123		2004-11-17
US60/628,145		2004-11-17
US60/628,112		2004-11-17
US60/628,156		2004-11-17
US60/628,167		2004-11-17
US60/628,231		2004-11-17
US60/628,134		2004-11-17
US60/628,251		2004-11-17
US60/628,101		2004-11-17
US11/043,842 US20060183131A1 (en)	2004-01-27	2005-01-27	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
US11/043,842		2005-01-27

Publications (2)

Publication Number	Publication Date
WO2005072050A2 WO2005072050A2 (en)	2005-08-11
WO2005072050A9 true WO2005072050A9 (en)	2010-01-14

Family

ID=34831604

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PCT/IB2005/000433 Ceased WO2005072050A2 (en)	2004-01-27	2005-01-27	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Country Status (3)

Country	Link
AU (1)	AU2005207882A1 (en)
CA (1)	CA2554440A1 (en)
WO (1)	WO2005072050A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1891218A2 (en) *	2005-06-08	2008-02-27	Compugen Ltd.	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
US20090215641A1 (en) *	2005-08-12	2009-08-27	Nihon University	Gene involved in occurrence/recurrence of hcv-positive hepatocelluar carcinoma
HUE034832T2 (en)	2008-12-09	2021-12-28	Hoffmann La Roche	Anti-pd-l1 antibodies and their use to enhance t-cell function
GB201004551D0 (en)	2010-03-19	2010-05-05	Immatics Biotechnologies Gmbh	NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer

2005
- 2005-01-27 CA CA002554440A patent/CA2554440A1/en not_active Abandoned
- 2005-01-27 AU AU2005207882A patent/AU2005207882A1/en not_active Abandoned
- 2005-01-27 WO PCT/IB2005/000433 patent/WO2005072050A2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2005207882A1 (en)	2005-08-11
CA2554440A1 (en)	2005-08-11
WO2005072050A2 (en)	2005-08-11

Publication	Publication Date	Title
WO2006131928A8 (en)	2007-07-19	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2004066941A3 (en)	2006-08-03	Expression profiles for colon cancer and methods of use
WO2005059108A3 (en)	2006-04-20	Gene expression profiles and methods of use
WO2007109236A3 (en)	2008-04-24	Microrna fingerprints during human megakaryocytopoiesis
WO2007081720A3 (en)	2008-02-14	Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
WO2005044990A3 (en)	2009-04-09	Use of differentially expressed nucleic acid sequences as biomarkers for cancer
WO2004065583A3 (en)	2005-03-03	Gene expression markers for breast cancer prognosis
WO2008017029A3 (en)	2008-11-13	Drug carriers, their synthesis, and methods of use thereof
AU2003233451A8 (en)	2003-10-13	Targets, methods, and reagents for diagnosis and treatment of schizophrenia
WO2007136736A3 (en)	2008-01-24	Methods for nucleic acid sorting and synthesis
IL172297A0 (en)	2006-04-10	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis iii
WO2008143668A3 (en)	2009-03-26	Indoleamine-2, 3-dioxygenase-2
WO2004078035A3 (en)	2006-04-27	Expression profiles for breast cancer and methods of use
WO2005032495A3 (en)	2006-06-01	Gene expression profiles and methods of use
WO2006009765A3 (en)	2006-05-11	Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2007120955A3 (en)	2008-02-14	Genes affecting human memory performance
WO2007058968A3 (en)	2008-11-20	Gene expression profiles and methods of use
WO2006054297A3 (en)	2009-04-30	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2005072050A9 (en)	2010-01-14	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
WO2009108949A3 (en)	2010-01-07	Cold shock protein compositions and methods and kits for the use thereof
WO2005072053A9 (en)	2010-03-04	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
EP1774046A4 (en)	2010-09-15	Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer
EP1954826A4 (en)	2010-05-05	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
AU2005288710A1 (en)	2006-04-06	Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
ZA200703482B (en)	2008-09-25	B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

Legal Events

Date	Code	Title	Description
2005-08-11	AK	Designated states	Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW
2005-08-11	AL	Designated countries for regional patents	Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
2006-07-26	WWE	Wipo information: entry into national phase	Ref document number: 2554440 Country of ref document: CA
2006-07-27	WWE	Wipo information: entry into national phase	Ref document number: 2006550364 Country of ref document: JP
2006-07-28	NENP	Non-entry into the national phase	Ref country code: DE
2006-07-28	WWE	Wipo information: entry into national phase	Ref document number: 2005207882 Country of ref document: AU
2006-07-28	WWW	Wipo information: withdrawn in national office	Country of ref document: DE
2006-08-24	ENP	Entry into the national phase	Ref document number: 2005207882 Country of ref document: AU Date of ref document: 20050127 Kind code of ref document: A
2006-08-24	WWP	Wipo information: published in national office	Ref document number: 2005207882 Country of ref document: AU
2006-08-25	WWE	Wipo information: entry into national phase	Ref document number: 2005718182 Country of ref document: EP
2006-12-13	121	Ep: the epo has been informed by wipo that ep was designated in this application
2006-12-20	WWP	Wipo information: published in national office	Ref document number: 2005718182 Country of ref document: EP